Prognostic Value of Serum Concentration of Heart-Type Fatty Acid-Binding Protein on Acute Coronary Syndrome at Early Stage

LIU Hai-bo,GUO Xiao-fang,ZHANG Li-mei,SHI Yu-ping,XU Geng,WANG Chun-ming

DOI: https://doi.org/10.3969/j.issn.1000-4718.2011.02-006

2011-01-01

Abstract:AIM: To investigate the prognostic value of serum concentration of heart-type fatty acid-binding protein(H-FABP) at early stage of acute coronary syndrome(ACS). METHODS: This was a prospective observational study with a follow-up of 12 months.The H-FABP was measured within 6 h after onset of chest pain in 172 consecutive patients hospitalized for ACS.The study endpoints were cardiac events,which were defined as cardiac death,subsequent nonfatal acute myocardial infarction(AMI),nonfatal heart failure and recurrent angina. RESULTS: During the period of 12-month follow-up,47 cardiac events,including 6 cardiac deaths,9 nonfatal AMIs,11 nonfatal heart failures and 21 recurrent anginas,were observed.The concentrations of H-FABP in the patients with cardiac events were significantly higher than those in the patients without cardiac events(P0.01).Meanwhile,the cardiac events were more prevalent in increased H-FABP(above the median of 12.5 μg/L) group(36 events vs 11 events,P0.01).In a Cox proportional hazards model that adjusted for baseline variables including demographics,clinical characteristics,ST deviation and troponin I,increased H-FABP(above the median of 12.5 μg/L) was independently associated with cardiac events in all patients[relative risk(RR)=5.430,P0.01;95% CI 2.587-11.398]. CONCLUSION: Elevation of H-FABP is associated with an increased risk of cardiac events in patients presenting across the spectrum of ACS and is independent of other established clinical risk predictors and biomarkers.